what products does pharmaceuticals make

SMS Pharmaceuticals Limited manufactures and sells Active Pharmaceutical Ingredients (APIs) and intermediates, including anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, and other specialty pharmaceutical products for both domestic and international markets.

what does pharmaceuticals do

SMS Pharmaceuticals Limited is a diversified and integrated pharmaceutical company that designs, manufactures, and markets APIs and intermediates through its global operations, supported by research and state-of-the-art facilities.

what sector is pharmaceuticals in

SMS Pharmaceuticals Limited operates in the pharmaceutical sector, specifically focusing on the manufacturing and supply of Active Pharmaceutical Ingredients (APIs) and intermediates.

when was pharmaceuticals founded

SMS Pharmaceuticals Limited was founded in 1990, starting as a single facility-single product manufacturer and expanding to become a global API manufacturer.

who owns pharmaceuticals

SMS Pharmaceuticals Limited is owned by its shareholders, with the company being a publicly traded entity on the stock exchanges in India.

SMSPHARMA

NSEBSE

SMS Pharmaceuticals Limited

Healthcare· Pharmaceuticals & Biotechnology· INE812G01025· Scrip: 532815

EN हिन्दी ગુજરાતી मराठी

₹४०६.००

▼ 4.10 (-1.00%)

1/5/2026, 9:45:09 am

NSE

₹४०६.००

▼ ४.१०

-१.००%

BSE

₹४०४.५५

▲ ५.२५

+०.००%

२४४ व्यापार दिन · 1Y कालावधी

आज 

उघडणे४१४.००

उच्चांक४१४.४५

नीचांक३९७.२५

मागील बंद४१०.१०

व्हॉल्यूम९.३७Cr

मूल्य₹०.३Cr

L: 397.25H: 414.45

52 आठवडे

नीचांक₹२०७.७०

उच्चांक₹४४७.८०

८३% 52 आठवड्यांच्या श्रेणीत

माहिती

दर्शनी मूल्य₹१

सूचीबद्ध2007-02-28

ISININE812G01025

SeriesB

BSE स्क्रिप532815

मुख्य निर्देशक

1D

-1.00%

1W

-2.30%

1M

+2.75%

3M

+31.12%

6M

+38.55%

मूल्यांकन

P/E (TTM)५१.९८

P/E (Qtr Ann.)४७.२१

P/Sales४.६७

बाजार भांडवल₹3643 Cr

वाढ (तिमाही)

महसूल-11.89%

PAT+29.38%

EPS+27.22%

नफाक्षमता

EBITDA मार्जिन१८.०%

निव्वळ मार्जिन१०.५%

TTM EBITDA M.१५.३%

TTM निव्वळ M.८.४%

लाभांश

परतावा०.१०%

अलीकडील DPS₹०.४

देय प्रमाण१८.६%

वाढ+0.00%

TTM महसूल

₹780 Cr

TTM EBITDA

₹119 Cr

TTM PAT

₹66 Cr

TTM EPS

₹७.८१

प्रति शेअर महसूल

₹८३.३

तिमाही वित्तीय

महसूल

EBITDA

PAT

EPS

तिमाही	महसूल	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	173 Cr	153 Cr	31 Cr	22 Cr	18 Cr	₹2.15
2024-09-30	197 Cr	179 Cr	28 Cr	20 Cr	14 Cr	₹1.69
2024-06-30	164 Cr	144 Cr	30 Cr	22 Cr	16 Cr	₹1.93
2024-03-31	246 Cr	226 Cr	30 Cr	22 Cr	17 Cr	₹2.04
2023-12-31	161 Cr	146 Cr	25 Cr	17 Cr	11 Cr	₹1.36
2023-09-30	167 Cr	152 Cr	23 Cr	15 Cr	12 Cr	₹1.39
2023-03-31	149 Cr	140 Cr	19 Cr	11 Cr	6 Cr	₹0.73
2022-12-31	149 Cr	144 Cr	15 Cr	7 Cr	4 Cr	₹0.44

शेअरहोल्डिंग नमुना

सध्याचे — 2026-03-31

प्रवर्तक68.1%

FII0.3%

DII3.0%

सार्वजनिक31.9%

प्रवर्तक होल्डिंग ट्रेंड

कॉर्पोरेट कार्यवाही

एक्स-तारीख	प्रकार	उद्देश
2025-09-22	Dividend	Dividend - Re 0.40 Per Share
2024-09-23	Other	Annual General Meeting
2024-09-23	Dividend	Dividend - Rs 0.40 Per Share
2023-09-22	Dividend	Dividend - Re 0.30 Per Share
2023-09-22	Other	Annual General Meeting
2022-09-22	Other	Annual General Meeting
2022-09-22	Dividend	Dividend - Re 0.30 Per Share
2021-09-22	Dividend	Annual General Meeting/ Dividend Rs 0.30 Per Share
2020-09-17	Other	Annual General Meeting
2020-03-26	Dividend	Interim Dividend - Rs 0.25 Per Share
2019-09-19	Dividend	Dividend - Rs 0.25 Per Share
2018-09-11	Dividend	Annual General Meeting/Dividend Re 0.25 Per Share
2017-09-20	Dividend	Annual General Meeting/Dividend - Rs 0.20 Per Share
2017-06-22	Other	Scheme Of Arrangement
2016-09-22	Dividend	Dividend Re 0.20 Per Share
2015-12-17	Split	Face Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per Share
2015-09-22	Dividend	Annual General Meeting/ Dividend - Rs 2/- Per Share
2014-09-23	Dividend	Annual General Meeting And Dividend Rs.2/- Per Share
2013-09-23	Dividend	Annual General Meeting / Dividend - Rs 2 Per Share
2012-09-20	Other	Annual General Meeting

उत्पन्न विवरण

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

10 Nov 2025NSE19K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

10 Aug 2025NSE12K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

31 May 2025NSE15K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

12 Feb 2025NSE13K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

9 Nov 2023NSE33K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

9 Aug 2023NSE29K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

25 May 2023NSE30K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional Inv...

23 Nov 2022NSE44K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

14 Nov 2022NSE32K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional Inv...

23 Aug 2022NSE38K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

13 Aug 2022NSE29K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional Inv...

9 Jun 2022NSE44K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

2 Jun 2022NSE30K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange regarding 'Re-schedule of Conference Call for ...

18 Feb 2022NSE1K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of conference call'.

11 Feb 2022NSE2K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange regarding 'Press release and investor presenta...

10 Feb 2022NSE39K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange regarding 'Earnings call Transcript Q2 FY22'.

23 Nov 2021NSE65K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange regarding 'Revised intimation of conference ca...

16 Nov 2021NSE2K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of Conference call Ref: ...

16 Nov 2021NSE2K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of conference callRef: R...

16 Nov 2021NSE2K chars

Read →

किंमत इतिहास

तारीख	उघडणे	उच्चांक	नीचांक	बंद	व्हॉल्यूम
2026-04-30	४१४.००	४१४.४५	३९७.२५	४०३.७०	२.०५L
2026-04-29	३९२.००	४१५.००	३९१.१०	४१०.१०	४.१६L
2026-04-28	३९९.६५	४०३.९०	३८७.००	३९०.२५	२.१२L
2026-04-27	३९७.२०	४०५.९०	३९५.००	३९९.६५	१.५१L
2026-04-24	४१८.५०	४१९.००	३९२.२०	३९६.७०	३.६६L
2026-04-23	४२०.२५	४३२.६०	४१३.००	४१५.५५	४.३५L
2026-04-22	४०५.१०	४२३.००	४०५.१०	४२०.२५	१.९९L
2026-04-21	४२३.००	४२४.८५	४०७.००	४०८.१०	२.१२L
2026-04-20	४२८.९५	४३३.५०	४१५.१०	४१७.७०	१.८९L
2026-04-17	४२५.८०	४३४.००	४२५.१०	४२९.००	१.६१L
2026-04-16	४३९.८५	४४६.००	४२१.४०	४२४.४०	४.००L
2026-04-15	४२५.००	४४७.८०	४२४.००	४३८.३०	६.१७L
2026-04-13	४१०.००	४२२.५०	३९७.६०	४१६.८५	२.५७L
2026-04-10	४२०.००	४२९.९५	४१४.१०	४१८.४०	४.१५L
2026-04-09	४००.००	४१९.९०	३९५.३०	४१५.००	५.११L
2026-04-08	४०५.९०	४०५.९०	३९३.१०	३९९.२०	२.१७L
2026-04-07	३८६.००	३९६.७०	३८३.०५	३९०.०५	२.१४L
2026-04-02	३८५.००	३९१.१५	३७०.२५	३८८.२५	३.८४L
2026-04-01	३९३.८०	४०४.९०	३८२.०५	३९२.७५	३.३५L
2026-03-27	३९८.९५	४१२.०५	३८५.००	३८६.१५	३.३७L
2026-03-25	३९५.५०	४१३.८०	३९४.००	४०४.५५	६.५३L
2026-03-24	३७६.६५	३९९.६०	३७२.६०	३९५.१५	५.२२L
2026-03-20	३६७.२५	३९४.२५	३६७.२५	३८५.०५	४.९२L
2026-03-19	३७६.५५	३७९.००	३६२.६०	३६६.१०	१.७२L
2026-03-18	३७५.१०	३८७.२०	३७३.९०	३८२.२५	२.२४L
2026-03-17	३६५.८०	३७८.८०	३६५.८०	३७२.७०	२.१७L
2026-03-16	३७०.००	३७९.९०	३५६.२०	३६६.१५	४.२३L
2026-03-13	४००.००	४०३.००	३६६.२५	३६८.७५	७.५८L
2026-03-12	४१०.००	४१९.९०	४०१.१०	४०५.२०	३.८०L
2026-03-11	४२२.००	४३३.९०	४११.०५	४१३.४०	७.७४L

वारंवार विचारले जाणारे प्रश्न

बद्दल

SMS फार्मास्युटिकल्स लिमिटेड, 1987 मध्ये स्थापन केलेली आणि हैदराबाद, भारत येथे मुख्यालय असलेली, एक एकीकृत फार्मास्युटिकल कंपनी आहे जी ऍन्टी-अल्सर, अँटी-फंगल, अँटी-मायग्रेन, अँटी-व्हायरल, अँटी-व्हायरल, अँटी-व्हायरल आणि अँटी-वायरल यांसारख्या उपचारात्मक श्रेणींमध्ये सक्रिय फार्मास्युटिकल इंग्रिडियंट्स (API) आणि जटिल इंटरमीडिएट्समध्ये विशेषज्ञ आहे. कंपनी एकाधिक उत्पादन सुविधा आणि संशोधन केंद्रे चालवते, 1,000 हून अधिक व्यावसायिकांना रोजगार देते आणि 10 पेक्षा जास्त उपचारात्मक उत्पादनांमध्ये जागतिक नेतृत्व स्थान धारण करते.

BOARD OF DIRECTORS

Vamsi Krishna Potluri

Whole-time Director

Shravan Kudaravalli

Independent Director

Srinivas Sarvepalli

Independent Director